Statement of Changes in Beneficial Ownership (4)
March 05 2020 - 4:11PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Fitzgerald Joseph Michael |
2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP
[
BSX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP & President, Rhythm Mgmt |
(Last)
(First)
(Middle)
300 BOSTON SCIENTIFIC WAY |
3. Date of Earliest Transaction
(MM/DD/YYYY)
3/3/2020 |
(Street)
MARLBOROUGH, MA 01752-1234
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 3/3/2020 | | M | | 3603.0000 | A | $0.0000 (1) | 222827.0000 | D | |
Common Stock | 3/3/2020 | | F | | 1779.0000 | D | $37.2300 | 221048.0000 | D | |
Common Stock | | | | | | | | 68401.0000 (2) | I | By 401(k) |
Common Stock | | | | | | | | 6777.0000 (3) | I | By Children |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Deferred Stock Units | (1) | 3/3/2020 | | M | | | 3603.0000 | (4) | 3/3/2022 (4) | Common Stock | 3603.0000 | $0.0000 | 7206.0000 | D | |
Explanation of Responses: |
(1) | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
(2) | Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. |
(3) | The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose. |
(4) | Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Fitzgerald Joseph Michael 300 BOSTON SCIENTIFIC WAY MARLBOROUGH, MA 01752-1234 |
|
| EVP & President, Rhythm Mgmt |
|
Signatures
|
/s/ Scott G. Hodgdon, Attorney-in-Fact | | 3/5/2020 |
**Signature of Reporting Person | Date |
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Sep 2023 to Sep 2024